Interestingly, hypoxia-upregulated miR-181a-5p reversed the inhibitory effects of Epirubicin treatment on BC cell proliferation, migration, invasion, and the expression of interstitial-related proteins through inhibiting EPDR1. Here, EPDR1 is linked to breast cancer.